Access Keys:
Skip to content (Access Key - 0)

NCI Center of Excellence in Integrative Cancer Biology and Genomics

The Center of Excellence in Integrative Cancer Biology and Genomics (CEICBG) is one of four Centers of Excellence established within the NCI Intramural Research Program (IRP). The Centers of Excellence build upon existing structures and areas of expertise. They lead new initiatives, projects, and collaborations, and position the IRP to play a significant role in interdisciplinary and multidisciplinary translational research. The CEICBG is a steward of resources and infrastructure, promotes interactions among NCI principal investigators and with other Institutes, extramural investigators, and the private sector, and provides leadership in facilitating new initiatives in cancer biology and genomics.

The CEICBG will promote the innovative use of genetic and genomic approaches and technologies for basic science discoveries and clinical research applications for the prevention, diagnosis, and treatment of cancer.

Objectives

  • Strengthen interactions across the IRP by providing a unique research environment and a capacity to take on "big" high risk projects
  • Enhance collaborative network among principal investigators and interactions with other NCI centers and programs
  • Consolidate existing cancer databases
  • Maximize utilization and accessibility of animal models
  • Expand core facilities
  • Provide a venue for annual meetings with participation from extramural scientists

To learn about recent advances by Center researchers, click on the images above.

Special Notices/Announcements

 

CEICBG Symposium

May 16, 2017
1:30pm- 4:30pm

Building 35, Room 620, NIH Bethesda campus

Program

Keynote speaker- Cyril Benes
Massachusetts General Hospital
" Modeling Drug Sensitivity and Resistance to Improve Cancer Care "

Snehal Gaikwad
Laboratory of Cancer Biology and Genetics, CCR, NCI
" Molecular Mechanism of Resistance to Proteasome Inhibitors"

Ruediger Meyer
Genetics Branch, CCR, NCI
" Clonal Heterogeneity and Treatment Response in Rectal Cancer"

Nityashree Shivaprasad
Genetics Branch, CCR, NCI
" FGFR4 Specific Chimeric Antigen Receptor (CAR) T Cell Therapy Against Rhabdomyosarcoma"

Thomas Ahearn
Integrative Tumor Epidemiology Branch, DCEG, NCI
" A Large-scale Genetic Association Study of Breast Cancer Subtypes"

For the flyer  click here

Current jobs in the CCR